A response that risks upfront acceptance of changes to deliver billions in new savings

September 11, 2024 Latest News BioPharma Comment

This is a preview of subscriber content

Subscribe now to continue reading.

The industry's decision to enthusiastically welcome the report means it has lost the opportunity to trade off the savings pathway for unambiguous improvements in access to therapies providing superior patient outcomes. …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Mark Butler steps in to block eye injection funding change after patient warnings
March 10, 2026 - Latest News
BPDInsights.ai has arrived as a new way to access knowledge
March 9, 2026 - Latest News
Pharmac says new agreement has improved access to treatment for New Zealanders
March 10, 2026 - Latest News
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 - Latest News
There is an ideology behind our funding systems, and it's the greatest barrier to change
March 11, 2026 - Latest News

A response that risks upfront acceptance of changes to deliver billions in new savings

This is a preview of subscriber content

Latest Video

Most Read

Mark Butler steps in to block eye injection funding change after patient warnings

BPDInsights.ai has arrived as a new way to access knowledge

Pharmac says new agreement has improved access to treatment for New Zealanders

Labor’s FoI backdown is a welcome victory for transparency and accountability

There is an ideology behind our funding systems, and it's the greatest barrier to change

New Stories

There is an ideology behind our funding systems, and it's the greatest barrier to change

New patient-led tool launched in Canberra to transform pain communication

Leader appointed to drive landmark Sydney biomedical hub toward global health breakthroughs

New digital partnership expands access to clinical guidance for Australian healthcare professionals

Self injection option offers new flexibility for Australians living with Myasthenia Gravis

CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production

Labor’s FoI backdown is a welcome victory for transparency and accountability

Sign In

A response that risks upfront acceptance of changes to deliver billions in new savings

This is a preview of subscriber content

Latest Video

Most Read

Mark Butler steps in to block eye injection funding change after patient warnings

BPDInsights.ai has arrived as a new way to access knowledge

Pharmac says new agreement has improved access to treatment for New Zealanders

Labor’s FoI backdown is a welcome victory for transparency and accountability

There is an ideology behind our funding systems, and it's the greatest barrier to change

Follow Us

New Stories

There is an ideology behind our funding systems, and it's the greatest barrier to change

New patient-led tool launched in Canberra to transform pain communication

Leader appointed to drive landmark Sydney biomedical hub toward global health breakthroughs

New digital partnership expands access to clinical guidance for Australian healthcare professionals

Self injection option offers new flexibility for Australians living with Myasthenia Gravis

CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production

Labor’s FoI backdown is a welcome victory for transparency and accountability